1.
Fertil Steril
; 84(6): 1755-7, 2005 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16359984
RESUMO
In women with polycystic ovary syndrome, chromium picolinate (200 microg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.